mAbs, Volume 4, Issue 5 (2012)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

mAbs, Volume 4, Issue 5 (2012)

See all volumes and issues
Vol 16, 2024 Vol 15, 2023 Vol 14, 2022 Vol 13, 2021 Vol 12, 2020 Vol 11, 2019 Vol 10, 2018 Vol 9, 2017 Vol 8, 2016 Vol 7, 2015 Vol 6, 2014 Vol 5, 2013 Volume 4, 2012 Vol 3, 2011 Vol 2, 2010 Vol 1, 2009
Download citations Download PDFs Download issue

Guest Editorial

Editorial
Mechanism of resistance to cetuximab therapy in colorectal cancer
Possible role of antibodies to immunoglobulin allotypes
Janardan P. Pandey
Pages: 553-554
Published online: 23 Jul 2012
CitationforMechanism of resistance to cetuximab therapy in colorectal cancer | Full Text | References | PDF (134.2 KB)
  • 655 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

Meeting Report

Meeting Report
The new ParaDIgm: IgM from bench to clinic
November 15–16, 2011, Frankfurt, Germany
Sherif Hanala
Pages: 555-561
Published online: 06 Aug 2012
AbstractforThe new ParaDIgm: IgM from bench to clinic | Full Text | References | PDF (218 KB)
  • 1130 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Meeting Report
2nd PEGS Annual Symposium on Antibodies for Cancer Therapy
April 30–May 1, 2012, Boston, USA
Mitchell Ho, Ivor Royston & Alain Beck
Pages: 562-570
Published online: 06 Aug 2012
Abstractfor2nd PEGS Annual Symposium on Antibodies for Cancer Therapy | Full Text | References | PDF (260.1 KB)
  • 1045 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
CD19 as an attractive target for antibody-based therapy
Ohad Hammer
Pages: 571-577
Published online: 23 Jul 2012
AbstractforCD19 as an attractive target for antibody-based therapy | PDF (227.6 KB)
  • 1395 Views
  • 70 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies
Yi Du, Alison Walsh, Robin Ehrick, Wei Xu, Kimberly May & Hongcheng Liu
Pages: 578-585
Published online: 23 Jul 2012
AbstractforChromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies | Full Text | References | PDF (229.1 KB)
  • 14470 Views
  • 199 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Peptibodies: A flexible alternative format to antibodies
Grant Shimamoto, Colin Gegg, Tom Boone & Christophe Queva
Pages: 586-591
Published online: 23 Jul 2012
AbstractforPeptibodies: A flexible alternative format to antibodies | PDF (404.4 KB)
  • 2416 Views
  • 84 CrossRef citations
  • 0Altmetric
Free Access

Report

Article
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
Yen Phung, Wei Gao, Yan-Gao Man, Satoshi Nagata & Mitchell Ho
Pages: 592-599
Published online: 23 Jul 2012
AbstractforHigh-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening | Full Text | References | PDF (1.6 MB)
  • 4574 Views
  • 64 CrossRef citations
  • 0Altmetric
Free Access
Article
Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis
Palanisamy Kanakaraj, Bridget A. Puffer, Xiao-Tao Yao, Spandana Kankanala, Ernest Boyd, Rutul R. Shah, Geping Wang, Dimki Patel, Rajesh Krishnamurthy, Shashi Kaithamana, Rodger G. Smith, David W. LaFleur, Carlos F. Barbas III, David M. Hilbert, Peter A. Kiener & Viktor V. Roschke
Pages: 600-613
Published online: 06 Aug 2012
AbstractforSimultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis | PDF (3.3 MB) | Supplemental
  • 788 Views
  • 37 CrossRef citations
  • 0Altmetric
Open Access
Article
Trifunctional antibody ertumaxomab: Non-immunological effects on Her2 receptor activity and downstream signaling
Simone Diermeier-Daucher, Olaf Ortmann, Stefan Buchholz & Gero Brockhoff
Pages: 614-622
Published online: 23 Jul 2012
AbstractforTrifunctional antibody ertumaxomab: Non-immunological effects on Her2 receptor activity and downstream signaling | PDF (1.5 MB)
  • 482 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
The assay design used for measurement of therapeutic antibody concentrations can affect pharmacokinetic parameters
Case studies
Saloumeh K. Fischer, Jihong Yang, Banmeet Anand, Kyra Cowan, Robert Hendricks, Jing Li, Gerald Nakamura & An Song
Pages: 623-631
Published online: 23 Jul 2012
AbstractforThe assay design used for measurement of therapeutic antibody concentrations can affect pharmacokinetic parameters | Full Text | References | PDF (1.3 MB)
  • 2647 Views
  • 34 CrossRef citations
  • 0Altmetric
Open Access

Editor's Corner

Editorial
2012 Upcoming Meetings
Janice M. Reichert
Pages: 632-633
Published online: 15 Aug 2012
Abstractfor2012 Upcoming Meetings | Full Text | PDF (160.2 KB)
  • 342 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Rapid depletion of “catch-and-release” anti-ASGR1 antibody in vivo
Siva Charan Devanaboyina et al.
Report | Published online: 25 Jul 2024
Open Access
Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers
Bill Liao et al.
Report | Published online: 24 Jul 2024
Open Access
Discovery and development of ANV419, an IL-2/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy
Patrizia Murer et al.
Report | Published online: 23 Jul 2024
Open Access
Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutations
Joel Heisler et al.
Report | Published online: 19 Jul 2024
Open Access